Source: MarketScreener

Constellation Pharmaceuticals Inc: PRESS RELEASE: Willkie Farr & Gallagher LLP: MorphoSys to acquire Constellation Pharmaceuticals

(marketscreener.com) DGAP-News: Willkie Farr & Gallagher LLP / Key word: Offer/Takeover Willkie Farr & Gallagher LLP: MorphoSys to acquire Constellation Pharmaceuticals 2021-06-08 / 11:10 The issuer is solely responsible for the content of this announcement....https://www.marketscreener.com/news/latest/PRESS-RELEASE-Willkie-Farr-Gallagher-LLP-MorphoSys-to-acquire-Constellation-Pharmaceuticals--35544444/?utm_medium=RSS&utm_content=20210608

Read full article »
Constellation Pharmaceuticals Inc's Competitors | Constellation Pharmaceuticals Inc's News | Constellation Pharmaceuticals Inc's Financials
Stay up-to-date with the latest news on Constellation
Est. Annual Revenue
$100K-5.0M
Est. Employees
100-250
Jigar Raythatha's photo - President & CEO of Constellation

President & CEO

Jigar Raythatha

CEO Approval Rating

98/100

Read more
Stay up-to-date with the latest news on Constellation